Cargando…

The Effects of Anti-inflammatory Drug Treatment in Gastric Cancer Prevention: an Update of a Meta-analysis

Gastric cancer has high incidence and fatality rates, making chemoprevention agents necessary. There is an ongoing debate about aspirin/nonsteroidal anti-inflammatory drugs (NSAIDs) use can significant reduce the risk of GC. We conducted a meta-analysis of existing studies evaluating the association...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kong, Pengfei, Wu, Ruiyan, Liu, Xuechao, Liu, Jianjun, Chen, Shangxiang, Ye, Minting, Yang, Chenlu, Song, Ze, He, Wenzhuo, Yin, Chenxi, Yang, Qiong, Jiang, Chang, Liao, Fangxin, Peng, Roujun, Zhou, Zhiwei, Xu, Dazhi, Xia, Liangping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166534/ https://www.ncbi.nlm.nih.gov/pubmed/27994661 http://dx.doi.org/10.7150/jca.16524

Ejemplares similares

Prognostic Impact of the Signet Ring Cell Type in Node-Negative Gastric Cancer
por: Kong, Pengfei, et al.
Publicado: (2016)

Association between Mismatch-repair Genetic variation and the Risk of Multiple Primary Cancers: A Meta-Analysis
por: Kong, Pengfei, et al.
Publicado: (2017)

Nomogram based on systemic inflammatory response markers predicting the survival of patients with resectable gastric cancer after D2 gastrectomy
por: Liu, Jianjun, et al.
Publicado: (2016)

Preoperative C-Reactive Protein/Albumin Ratio Predicts Prognosis of Patients after Curative Resection for Gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2015)

Prognostic value of pretreatment albumin–globulin ratio in predicting long-term mortality in gastric cancer patients who underwent D2 resection
por: Liu, Jianjun, et al.
Publicado: (2017)

Prognostic significance of Epstein-Barr virus infection in gastric cancer: a meta-analysis
por: Liu, Xuechao, et al.
Publicado: (2015)

The Efficacy of Bevacizumab in Different Line Chemotherapy for Chinese Patients with Metastatic Colorectal Cancer
por: Yin, Chenxi, et al.
Publicado: (2016)

Impact of systemic inflammation on gastric cancer outcomes
por: Liu, Xuechao, et al.
Publicado: (2017)

Longterm effects of palliative local treatment of incurable metastatic lesions in colorectal cancer patients
por: Yang, Qiong, et al.
Publicado: (2016)

Clinical utility of HER2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes
por: Chen, Shangxiang, et al.
Publicado: (2017)

Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer
por: Sun, Xiaowei, et al.
Publicado: (2016)

A Novel Prognostic Score, Based on Preoperative Nutritional Status, Predicts Outcomes of Patients after Curative Resection for Gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Combined preoperative concentrations of CEA, CA 19-9, and 72-4 for predicting outcomes in patients with gastric cancer after curative resection
por: Liu, Xuechao, et al.
Publicado: (2016)

Bevacizumab plus chemotherapy as third- or later-line therapy in patients with heavily treated metastatic colorectal cancer
por: Yang, Qiong, et al.
Publicado: (2015)

A high LDL-C to HDL-C ratio predicts poor prognosis for initially metastatic colorectal cancer patients with elevations in LDL-C
por: Liao, Fangxin, et al.
Publicado: (2015)

Development and external validation of a prognostic nomogram for gastric cancer using the national cancer registry
por: Liu, Jianjun, et al.
Publicado: (2016)

Albumin concentrations plus neutrophil lymphocyte ratios for predicting overall survival after curative resection for gastric cancer
por: Sun, Xiaowei, et al.
Publicado: (2016)

Gastric cancer, nutritional status, and outcome
por: Liu, Xuechao, et al.
Publicado: (2017)

Initial LDH level can predict the survival benefit from bevacizumab in the first-line setting in Chinese patients with metastatic colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2014)

Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2020)

First-line cetuximab improves the efficacy of subsequent bevacizumab for RAS wild-type left-sided metastatic colorectal cancer: an observational retrospective study
por: Liu, Shousheng, et al.
Publicado: (2020)

Preoperative Nutritional Deficiency Is a Useful Predictor of Postoperative Outcome in Patients Undergoing Curative Resection for Gastric Cancer
por: Liu, Xuechao, et al.
Publicado: (2016)

Combination of CRP and NLR: a better predictor of postoperative survival in patients with gastric cancer
por: Guo, Jing, et al.
Publicado: (2018)

Circulating Lymphocytes, PD-L1 Expression on Tumor-infiltrating Lymphocytes, and Survival of Colorectal Cancer Patients with Different Mismatch Repair Gene Status
por: Kong, Pengfei, et al.
Publicado: (2019)

A novel classifier based on three preoperative tumor markers predicting the cancer-specific survival of gastric cancer (CEA, CA19-9 and CA72-4)
por: Guo, Jing, et al.
Publicado: (2017)

Phosphorylation by mTORC1 stablizes Skp2 and regulates its oncogenic function in gastric cancer
por: Geng, Qirong, et al.
Publicado: (2017)

Brain metastases in newly diagnosed colorectal cancer: a population-based study
por: Yang, Lin, et al.
Publicado: (2018)

A 3-MicroRNA Signature Identified From Serum Predicts Clinical Outcome of the Locally Advanced Gastric Cancer
por: Chen, Shangxiang, et al.
Publicado: (2020)

Proximal shift of colorectal cancer with increasing age in different ethnicities
por: Yang, Lin, et al.
Publicado: (2018)

Prognostic value of total number of lymph nodes retrieved differs between left-sided colon cancer and right-sided colon cancer in stage III patients with colon cancer
por: Yang, Lin, et al.
Publicado: (2018)

Second primary colorectal cancer after the initial primary colorectal cancer
por: Yang, Lin, et al.
Publicado: (2018)

Impact of preoperative anemia on outcomes in patients undergoing curative resection for gastric cancer: a single‐institution retrospective analysis of 2163 Chinese patients
por: Liu, Xuechao, et al.
Publicado: (2018)

Characterisation of tumor microenvironment and prevalence of CD274/PD-L1 genetic alterations difference in colorectal Cancer
por: Yang, Lin, et al.
Publicado: (2023)

Safety and Efficacy of Long-Term Zoledronic Acid in Advanced Breast Cancer with Bone Metastasis in South China
por: Wang, Qianyu, et al.
Publicado: (2020)

Tumor microenvironment classification based on T-cell infiltration and PD-L1 in patients with mismatch repair-proficient and -deficient colorectal cancer
por: Liu, Shousheng, et al.
Publicado: (2019)

Clinical baseline and prognostic difference of platelet lymphocyte ratio (PLR) in right-sided and let-sided colon cancers
por: Yang, Lin, et al.
Publicado: (2017)

Predictive value of prognostic nutritional and systemic immune-inflammation indices for patients with microsatellite instability-high metastatic colorectal cancer receiving immunotherapy
por: Yi, Jiahong, et al.
Publicado: (2023)

Alterations in the gastric microbiota and metabolites in gastric cancer: An update review
por: Lei, Changzhen, et al.
Publicado: (2022)

The Prognostic and Predictive Value of Carbohydrate Antigen 19-9 in Metastatic Colorectal Cancer Patients with First Line Bevacizumab Containing Chemotherapy
por: Jiang, Chang, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ad19ni7cpne5goio7k7d6552a9